|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
1999-1-11
|
|
pubmed:abstractText |
Etoposide is a highly schedule-dependent drug. We investigated combination chemotherapy of oral etoposide and intravenous cisplatin for small cell lung cancer (SCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0368-2811
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
745-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9879292-Administration, Oral,
pubmed-meshheading:9879292-Adult,
pubmed-meshheading:9879292-Aged,
pubmed-meshheading:9879292-Alopecia,
pubmed-meshheading:9879292-Anemia,
pubmed-meshheading:9879292-Anorexia,
pubmed-meshheading:9879292-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9879292-Carcinoma, Small Cell,
pubmed-meshheading:9879292-Cisplatin,
pubmed-meshheading:9879292-Drug Administration Schedule,
pubmed-meshheading:9879292-Etoposide,
pubmed-meshheading:9879292-Female,
pubmed-meshheading:9879292-Humans,
pubmed-meshheading:9879292-Infusions, Intravenous,
pubmed-meshheading:9879292-Leukopenia,
pubmed-meshheading:9879292-Lung Neoplasms,
pubmed-meshheading:9879292-Male,
pubmed-meshheading:9879292-Middle Aged,
pubmed-meshheading:9879292-Nausea,
pubmed-meshheading:9879292-Thrombocytopenia,
pubmed-meshheading:9879292-Vomiting
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Cisplatin plus oral etoposide in the treatment of patients with advanced small cell lung cancer. Japan Clinical Oncology Group.
|
|
pubmed:affiliation |
Department of Respiratory Diseases, Kyoto National Hospital, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
